why choose us

First received: November 14, 2022

Clinical Trial: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Study Status: Completed

Recruit Status: RECRUITING

Condition: Treatment Resistant Depression

Study Type: INTERVENTIONAL


Official Title: A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression

Brief Summary: Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

Read more